Interestingly, our data were also consistent with previous findings, as the combination of CD39 blockade and aPDL1 11 as well as UTMC and aPDL1 36, 39, has been shown to enhance CTL infiltration and improve aPDL1-mediated anti-tumor immune responses. Here, ENTPD1 is linked to neoplasm.